Springer Nature

memo - Magazine of European Medical Oncology Template

Write in a clean editor, then format for memo - Magazine of European Medical Oncology in one click — DocuGuru applies the official Springer Nature template with superscript references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the memo - Magazine of European Medical Oncology format

memo - Magazine of European Medical Oncology is a peer-reviewed journal published by Springer Nature, covering Lymphoma Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Chronic Lymphocytic Leukemia Research.

PublisherSpringer Nature
Reference styleSuperscript numbered (Nature)
Superscript — small raised numerals in the text
1. Smith, A., Jones, B. & Lee, C. A representative article title. memo - Magazine of European Medical Oncology 12, 45–58 (2023).

Formats any DOI in memo - Magazine of European Medical Oncology style. No sign-up.

Publishes research inLymphoma Diagnosis and Treatment Lung Cancer Treatments and Mutations Chronic Lymphocytic Leukemia Research Cancer Genomics and Diagnostics Acute Myeloid Leukemia Research
ISSN1865-5041
Citation impact (2-yr)0.76
h-index26
i10-index81
Total citations3,322
Article processing charge$4,390
Top institutions publishing hereMedical University of Vienna
Journal websitewww.springer.com
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in memo - Magazine of European Medical Oncology per year

66
2014
57
2015
57
2016
69
2017
86
2018
85
2019
116
2020
110
2021
75
2022
87
2023
68
2024
75
2025

Citation impact of memo - Magazine of European Medical Oncology by publication year

146
2014
61
2015
280
2016
405
2017
474
2018
205
2019
322
2020
431
2021
112
2022
95
2023
79
2024
41
2025

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in memo - Magazine of European Medical Oncology

Pitfalls in the radiological response assessment of immunotherapy

Lucian Beer, Maximilian J. Hochmair, Helmut Prosch · 21 Mar 2018

Immunotherapies comprise of a class of cancer therapies that are increasingly used for treatment of several cancer entities. Active immunotherapies encompassing immune checkpoint inhibitors are the most widespread class of immunotherapies, with indications for melanoma, non-small lung cancer, renal cell carcinoma, urothelial carcinoma, head and neck squamous cell carcinoma, and Hodgkin's lymphoma. Immune checkpoint inhibitors…

Malnutrition and cancer, diagnosis and treatment

Angelika Beirer · 1 Apr 2021

Summary Background The prevalence of malnutrition in cancer patients ranges from about 20% to more than 70%. However, 10–20% of cancer patients’ deaths are related to malnutrition, not the malignancy itself. To reverse the pattern of weight loss, improve the patients’ quality of life, reduce the treatment toxicity, the psychological stress and the risk of…

New diagnostic tools for breast cancer

Pascal Baltzer, Panagiotis Kapetas, Maria Adele Marino et al. · 28 Jun 2017

Imaging plays a major role in the diagnosis, treatment, and follow-up of breast cancer. Findings that require further assessment will be detected both at screening and curative mammography. Most findings that are further worked up tend to yield benign diagnoses. Consequently, there is an ongoing search for new tools to reduce recalls and unnecessary biopsies…

Aggressive lymphoma 2016: revision of the WHO classification

Christine Beham‐Schmid · 30 Nov 2017

Aggressive lymphomas are a heterogeneous group of malignancies reflecting clinical, biological and pathological diversity. Diffuse large B‑cell lymphoma is the most common histological subtype and therefore will constitute the key aspect in this article. This lymphoma affects patients of all age groups with wide range presentations concerning localization, morphology and molecular mechanisms. The median age…

WHO classification of tumors of the nervous system: preview of the upcoming 5th edition

Elisabeth J. Rushing · 12 Feb 2021

Summary Identification of the underlying genetic and epigenetic alterations in an increasing number of tumors of the nervous system is contributing to a more clinically relevant classification. In the following article, the 7 cIMPACT-NOW publications, which adumbrate the upcoming 5th edition of the WHO Classification of Tumours of the Central Nervous Sytem are summarized.

memo - Magazine of European Medical Oncology template — frequently asked questions

How do I write a paper in the memo - Magazine of European Medical Oncology format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the memo - Magazine of European Medical Oncology template. When you export, DocuGuru compiles the paper into the official Springer Nature format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does memo - Magazine of European Medical Oncology use?
memo - Magazine of European Medical Oncology uses Superscript numbered (Nature) references, shown as superscript numerals in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: 1. Smith, A., Jones, B. & Lee, C. A representative article title. memo - Magazine of European Medical Oncology 12, 45–58 (2023).
Do I need to know LaTeX to submit to memo - Magazine of European Medical Oncology?
No. DocuGuru generates the sn-jnl LaTeX class and compiles the PDF for you in the background, so you get a Springer Nature-ready memo - Magazine of European Medical Oncology document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the memo - Magazine of European Medical Oncology template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the memo - Magazine of European Medical Oncology format with correct headings, figures, tables, and superscript citations.
Who publishes memo - Magazine of European Medical Oncology?
memo - Magazine of European Medical Oncology is a multidisciplinary journal published by Springer Nature. DocuGuru's memo - Magazine of European Medical Oncology template matches Springer Nature's official submission format.
Can I export a submission-ready memo - Magazine of European Medical Oncology PDF?
Yes — DocuGuru produces a PDF built with the official memo - Magazine of European Medical Oncology template (the sn-jnl class) that is ready to submit to Springer Nature, together with the matching LaTeX source files.
How much does the memo - Magazine of European Medical Oncology template cost?
You can start writing in the memo - Magazine of European Medical Oncology template for free. Exporting the final submission-ready memo - Magazine of European Medical Oncology PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the memo - Magazine of European Medical Oncology template